UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients

Diabetologia, 2001-03, Vol.44 (3), p.305-308

2001

Volltextzugriff (PDF)

Interleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes

British journal of dermatology (1951), 2011-09, Vol.165 (3), p.492-498

2011

Volltextzugriff (PDF)

Insulin kinetics in type-1 diabetes: continuous and bolus delivery of rapid acting insulin

IEEE transactions on biomedical engineering, 2005-01, Vol.52 (1), p.3-12

2005

Volltextzugriff (PDF)

Bioavailability of insulin detemir and human insulin at the level of peripheral interstitial fluid in humans, assessed by open-flow microperfusion

Diabetes, obesity & metabolism, 2015-12, Vol.17 (12), p.1166-1172

2015

Volltextzugriff (PDF)

E-voting: from apathy to adoption

Journal of enterprise information management, 2005-01, Vol.18 (5), p.586-601

2005

Volltextzugriff (PDF)

Clinical applicability of dOFM devices for dermal sampling

Skin research and technology, 2013-11, Vol.19 (4), p.474-483

2013

Volltextzugriff (PDF)

A Generic Integrated Physiologically based Whole‐body Model of the Glucose‐Insulin‐Glucagon Regulatory System

CPT: pharmacometrics and systems pharmacology, 2013-08, Vol.2 (8), p.1-10

2013

Volltextzugriff (PDF)

Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patients

Diabetes, obesity & metabolism, 2014-02, Vol.16 (2), p.137-146

2014

Volltextzugriff (PDF)

IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion

Experimental dermatology, 2012-02, Vol.21 (2), p.104-110

2012

Volltextzugriff (PDF)

Clinical performance of a low cost near infrared sensor for continuous glucose monitoring applied with subcutaneous microdialysis

Biomedical microdevices, 2015-08, Vol.17 (4), p.73-10, Article 73

2015

Volltextzugriff (PDF)

On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes

Diabetic medicine, 2006-01, Vol.23 (1), p.90-93

2006

Volltextzugriff (PDF)

21 Integrative computational analysis of longitudinal effects of elexacaftor/tezacaftor/ivacaftor on sputum microbiome and proteome in people with cystic fibrosis

Journal of cystic fibrosis, 2024-09, Vol.23, p.S11-S11

2024

Volltextzugriff (PDF)

WS13.05 Intrapulmonary treatment with Ligilactobacillus murinus reduces airway inflammation and mucus plugging in neonatal βENaCtransgenic mice with cystic fibrosis-like lung disease

Journal of cystic fibrosis, 2024-06, Vol.23, p.S25-S25

2024

Volltextzugriff (PDF)

Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients

Diabetologia, 2001-03, Vol.44 (3), p.305-308

2001

Volltextzugriff (PDF)

Identification of early neurodegenerative pathways in progressive multiple sclerosis

Nature neuroscience, 2022-07, Vol.25 (7), p.944-955

2022

Volltextzugriff (PDF)

Post-prandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus

Diabetic medicine, 2000-05, Vol.17 (5), p.371-375

2000

Volltextzugriff (PDF)

A toolbox to improve algorithms for insulin-dosing decision support

Applied clinical informatics, 2014-01, Vol.5 (2), p.548-556

2014

Volltextzugriff (PDF)

A novel automated discontinuous venous blood monitoring system for ex vivo glucose determination in humans

Biosensors & bioelectronics, 2009-03, Vol.24 (7), p.2239-2245

2009

Volltextzugriff (PDF)

Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes

Physiological measurement, 2004-08, Vol.25 (4), p.905-920

2004

Volltextzugriff (PDF)

Continuous Blood Glucose Monitoring (Cgm) System Based on Intravenous Microdialysis and Glucose Sensing

Biomedizinische Technik, 2013-09, Vol.58 Suppl 1

2013

Volltextzugriff (PDF)

66 Longitudinal effects of elexacaftor-tezacaftor-ivacaftor therapy on airway infection and inflammation in people with cystic fibrosis

Journal of cystic fibrosis, 2023-10, Vol.22, p.S35-S35

2023

Volltextzugriff (PDF)

178 Longitudinal effects of elexacaftor-tezacaftor-ivacaftor therapy on viscoelastic properties of sputum in people with cystic fibrosis

Journal of cystic fibrosis, 2023-10, Vol.22, p.S93-S94

2023

Volltextzugriff (PDF)

U-government: a framework for the evolution of e-government

Electronic government, 2005, Vol.2 (3), p.426

2005

Volltextzugriff (PDF)

EPS6.01 Effects of elexacaftor/tezacaftor/ivacaftor therapy on sputum viscoelasticity, airway infection and inflammation in patients with cystic fibrosis

Journal of cystic fibrosis, 2023-06, Vol.22, p.S52-S52

2023

Volltextzugriff (PDF)

Validation of home blood glucose meters with respect to clinical and analytical approaches

Diabetes care, 1998-04, Vol.21 (4), p.585-590

1998

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients

Interleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes

Insulin kinetics in type-1 diabetes: continuous and bolus delivery of rapid acting insulin

Bioavailability of insulin detemir and human insulin at the level of peripheral interstitial fluid in humans, assessed by open-flow microperfusion

E-voting: from apathy to adoption

Clinical applicability of dOFM devices for dermal sampling

A Generic Integrated Physiologically based Whole‐body Model of the Glucose‐Insulin‐Glucagon Regulatory System

Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patients

IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion

Clinical performance of a low cost near infrared sensor for continuous glucose monitoring applied with subcutaneous microdialysis

On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes

21 Integrative computational analysis of longitudinal effects of elexacaftor/tezacaftor/ivacaftor on sputum microbiome and proteome in people with cystic fibrosis

WS13.05 Intrapulmonary treatment with Ligilactobacillus murinus reduces airway inflammation and mucus plugging in neonatal βENaCtransgenic mice with cystic fibrosis-like lung disease

Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients

Identification of early neurodegenerative pathways in progressive multiple sclerosis

Post-prandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus

A toolbox to improve algorithms for insulin-dosing decision support

A novel automated discontinuous venous blood monitoring system for ex vivo glucose determination in humans

Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes

Continuous Blood Glucose Monitoring (Cgm) System Based on Intravenous Microdialysis and Glucose Sensing

66 Longitudinal effects of elexacaftor-tezacaftor-ivacaftor therapy on airway infection and inflammation in people with cystic fibrosis

178 Longitudinal effects of elexacaftor-tezacaftor-ivacaftor therapy on viscoelastic properties of sputum in people with cystic fibrosis

U-government: a framework for the evolution of e-government

EPS6.01 Effects of elexacaftor/tezacaftor/ivacaftor therapy on sputum viscoelasticity, airway infection and inflammation in patients with cystic fibrosis

Validation of home blood glucose meters with respect to clinical and analytical approaches

Suchergebnisse filtern